US2006093587A1PendingUtilityA1
Transplants for myocardial scars
Est. expiryMay 28, 2017(expired)· nominal 20-yr term from priority
C12N 2501/70A61K 38/00C12N 5/0661A61P 9/04C12N 5/0657A61K 48/00C12N 2509/00A61K 35/12C12N 5/0656C12N 2502/28C12N 5/069C12N 5/0691A61K 35/34C12N 2510/00C12N 2500/44
61
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A method is provided for forming a graft in heart tissue which comprises the transplantation of cells chosen from cardiomyocytes, fibroblasts, smooth muscle cells, endothelial cells and skeletal myoblasts. The grafts are especially useful in treating scar tissue on the heart.
Claims
exact text as granted — not AI-modified1 . A method of forming a stable cardiac graft in a mammal, said method comprising transplanting skeletal myoblasts and fibroblasts into the scar tissue of a heart,
wherein said skeletal myoblasts and fibroblasts survive in scar tissue in a heart after transplantation into said scar tissue, and wherein said skeletal myoblasts and fibroblasts improve cardiac function, relative to cardiac function of a heart having similar myocardial scar tissue that is not transplanted with said skeletal myoblasts.
2 . The method of claim 1 , wherein cardiac function is assessed by at least one of the criteria in the group consisting of: area occupied by said scar tissue; vascularization of said scar tissue; blood flow to said scar tissue; developed pressure, systolic pressure; end diastolic pressure; and Δpressure/Δtime.
3 . The method of claim 1 , wherein at least 10% of said scar tissue is occupied by transplanted cells four weeks after plantation.
4 . The method of claim 1 , wherein said graft is used for cardiomyoplasty.
5 . The method of claim 1 , wherein said graft is used for closing cardiac defects.
6 . The method of claim 1 , wherein said graft is used for myocardial reconstructive surgery.Join the waitlist — get patent alerts
Track US2006093587A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.